Tradestie Institutional Equity Comparison Engine

CDT vs SPRC โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CDT Overall Edge

CDT Captures Institutional Edge (2โ€“1 Pillars ยท 4โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to CDT Equity Inc. Common Stock (CDT) driven by superior Growth & Margin, Momentum & Technical while SPRC counters with relative strength in Options & Structure. Fundamentally, CDT trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus SPRC at N/M Forward P/E and -725.2% operating margin (-38.4% YoY). In options structure, CDT sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against SPRC sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CDT N/M vs SPRC N/M Fwd P/E
Growth & Margin Winner CDT
Op Margin 0.0% vs -725.2% ยท YoY +0.0% vs -38.4%
Momentum & Technical Winner CDT
1Y -86.8% vs -92.0% ยท 52W Pos 2% vs 0%
Options & Structure Winner SPRC
BREAKDOWN (N/A IV) vs BREAKDOWN (N/A IV)
CDT NASDAQ
CDT Equity Inc. Common Stock
Pharmaceutical Preparations
$0.23
-13.89% 1D
Market Cap $507,528
1M Return +76.79%
1Y Return -86.78%
Forward P/E N/M
Unified AI Score
31.6 / 100 SELL
Tech 15.0 Fund 37.0 Flow 50.0 Mom 54.0
SPRC NASDAQ
SciSparc Ltd. Ordinary Shares
Retail-Auto Dealers & Gasoline Stations
$0.20
-34.83% 1D
Market Cap $739,034
1M Return -83.71%
1Y Return -92.05%
Forward P/E N/M
Unified AI Score
44.2 / 100 HOLD
Tech 25.0 Fund 43.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CDT -86.78% SPRC -92.05% Spread: +5.27 pp (CDT Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CDT TTM Op. Margin: 0.0% SPRC TTM Op. Margin: -725.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDT vs SPRC. Trailing 12-month operating profitability (CDT 0.0% vs SPRC -725.2%) and valuation multiples (CDT N/M vs SPRC N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CDT (4) vs SPRC (2)
Institutional Metric CDT SPRC Criterion Row Winner
Market Capitalization Scale $507,528 $739,034 Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -38.4% Higher Growth CDT
Operating Margin (TTM) Profitability 0.0% -725.2% Higher Margin CDT
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -69.7% -164.5% Higher ROE CDT
52-Week Range Position Momentum 2% ($0โ€“$11) 0% ($0โ€“$16) Stronger Trend CDT
Beta / 30D Volatility Risk Regime -17.75ฮฒ ยท 10175% Vol 0.93ฮฒ ยท 205% Vol Lower Realized Risk SPRC
Unified Institutional Score Composite Signal 31.6 / 100 (SELL) 44.2 / 100 (HOLD) Higher Composite SPRC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CDT vs SPRC Buy Guide
CDT BREAKDOWN
163d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDT Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SPRC BREAKDOWN
117d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SPRC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CDT nor SPRC registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.